Case Report on Polycythemia Vera and Sweet Syndrome Treatment with Ruxolitinib

A 1.3 MB PDF case report authored by Axel Rüfer details a male patient with Polycythemia vera in remission who developed Sweet syndrome. The report describes successful treatment of both conditions with the JAK1/2 inhibitor ruxolitinib, leading to persistent remission and complete resolution. The dataset was last updated on 2026-04-28 and is shared under a CC-BY-4.0 license on figshare.

Use Cases

• Analyze treatment outcomes for malignancy-associated Sweet syndrome based on the described clinical case.
• Study the use of ruxolitinib as a therapeutic option for Polycythemia vera complications based on the reported success.
• Investigate the relationship between Polycythemia vera remission and histiocytoid Sweet syndrome presentation based on the case details.

Strengths

• The dataset is a detailed clinical case report describing a specific and successful treatment regimen.
• It is shared under a permissive CC-BY-4.0 license, allowing for broad reuse and distribution.

Limitations

• The dataset is a single case report (N=1), limiting statistical power and generalizability of findings.
• Row count and column-level documentation are absent; the data structure must be inferred from the PDF text.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

figshare

Collection Method

Likely a clinical case report authored by a medical professional.

Freshness

Last updated 2026-04-28 08:59:39; freshness should be verified.